Fineline Cube

Follow:
14486 Articles
CompanyDeals

Duality Biologics and Avenzo Ink Exclusive License for DB-1418/AVZO-1418

MSD's Gardasil Vaccine Gains NMPA Approval for Use in Males Aged 9 to 26
CompanyDrug

MSD’s Gardasil Vaccine Gains NMPA Approval for Use in Males Aged 9 to 26

Bayer's Nubeqa Seeks NMPA Approval for New Prostate Cancer Indication
CompanyDrug

Bayer’s Nubeqa Seeks NMPA Approval for New Prostate Cancer Indication

GE Healthcare's Allia IGS Pulse Receives NMPA Clearance for Launch in China
CompanyMedical Device

GE Healthcare’s Allia IGS Pulse Receives NMPA Clearance for Launch in China

Avenzo Therapeutics Licenses Duality Biologics' EGFR/HER3 Bispecific ADC AVZO-1418/DB-1418
CompanyDeals

Avenzo Therapeutics Licenses Duality Biologics’ EGFR/HER3 Bispecific ADC AVZO-1418/DB-1418

Inceptor Bio and GRIT Biotechnology Partner to Advance CAR-T Therapy IB-T101 for Solid Tumors
CompanyDeals

Inceptor Bio and GRIT Biotechnology Partner to Advance CAR-T Therapy IB-T101 for Solid Tumors

Kexing and Kelun Partner to Expand Overseas Business for Generic Drugs and Therapies
CompanyDeals

Kexing and Kelun Partner to Expand Overseas Business for Generic Drugs and Therapies

PKU 1st Hospital Partners with Baheal Pharmaceutical on Integrin-Targeted Inhibitor Project
CompanyDeals

PKU 1st Hospital Partners with Baheal Pharmaceutical on Integrin-Targeted Inhibitor Project

Takeda and Fudan University's IMI Launch AI-Based Rare Disease Screening and Diagnosis Project
CompanyDeals

Takeda and Fudan University’s IMI Launch AI-Based Rare Disease Screening and Diagnosis Project

LinkedCare Raises Hundreds of Millions in Series E Funding Led by State-Owned Investors
CompanyDeals

LinkedCare Raises Hundreds of Millions in Series E Funding Led by State-Owned Investors

Grand Life Sciences Partners with Cali Biosciences for CPL-01 Commercialization in China
CompanyDeals

Grand Life Sciences Partners with Cali Biosciences for CPL-01 Commercialization in China

Insilico Medicine's ISM5411 Shows Positive Results in Phase I Studies for Inflammatory Bowel Disease
CompanyDrug

Insilico Medicine’s ISM5411 Shows Positive Results in Phase I Studies for Inflammatory Bowel Disease